Abstract
The spatial distribution of surveillance-reported dengue cases and severity are usually analyzed separately, assuming independence between the spatial distribution of non-severe and severe cases. Given the availability of data for the individual geo-location of surveillance-notified dengue cases, we conducted a spatial analysis to model non-severe and severe dengue simultaneously, using a hierarchical Bayesian model. We fit a joint model to the spatial pattern formed by dengue cases as well as to the severity status of the cases. Results showed that age and socioeconomic status were associated with dengue presence, and there was evidence of clustering for overall cases but not for severity. Our findings inform decision making to address the preparedness or implementation of dengue control strategies at the local level.
Highlights
A model to jointly assess the spatial distribution of reported dengue and severity.
We account for uncertainty in the surveillance-reported dengue while modelling severe cases.
We assess spatial clustering of dengue and severe dengue cases in Medellin.
Non-monotonic distribution of reported dengue cases across socioeconomic status.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study analyzed secondary data without identifying information, and therefore, did not require informed consent. The protocol was reviewed and approved by the Institutional Review Board (Study No. A02-E05-18A) and by the ethics committee of the Secretary of Health of Medellin, Colombia.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data accessibility: Case-specific data, which is routinely collected using the national surveillance system of Colombia (SIVIGILA; http://portalsivigila.ins.gov.co/sivigila/index.php) was obtained directly form the Local Surveillance office (Secretaria de Salud Municipal de Medellin); Socioeconomic information at neighborhood level was obtained from the website of the municipality (https://www.medellin.gov.co) and an open data source for socioeconomic information (https://www.datos.gov.co/).
Abbreviations
- Cr.Int
- Credible Interval
- SRR
- Standardized Rate Ratio
- IQR
- Interquartile Range
- OR
- Odds Ratio
- RR
- Relative Risk
- DIC
- Deviation Information Criterion
- INLA
- Integrated Nested Laplace Approximation
